Last reviewed · How we verify

NCT05145855

The Effects of Offline Anosognosia For Spatial Neglect on Neglect Rehabilitation

Completed Last updated 2 December 2022
What this trial tests

trial testing Patient-tailored multimodal neglect rehabilitation in Hemispatial Neglect in 85 participants. Completed in 15 December 2021.

Timeline
29 November 2021
Primary endpoint
15 December 2021
15 December 2021

Quick facts

Lead sponsorGazi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment85
Start date29 November 2021
Primary completion15 December 2021
Estimated completion15 December 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

18 and older, any sex, with Hemispatial Neglect or Hemiplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anosognosia for hemispatial neglect is an intriguing phenomenon characterized by decreased awareness of spatial deficits, common in patients with right hemisphere stroke. However, it has not been examined as extensively as anosognosia for hemiplegia. In this study, we aim to investigate the relationship between the decrease in anosognosia for neglect and the improvement of spatial deficits.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of offline anosognosia for hemispatial neglect on neglect rehabilitation in patients with subacute and chronic right hemispheric brain injury. A retrospective cohort study.
    Karataş L, Utkan Karasu A, Karataş GK. · · 2024 · cited 1× · PMID 37073753 · DOI 10.1080/09602011.2023.2202862

Verify or expand the search:

Other recruiting trials for Hemispatial Neglect

Currently open trials in the same condition.

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05145855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing